See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 31, 2002

Uterine Fibroids Diabetes Mellitus Types I and II Malignant Melanoma

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Uterine Fibroids

A multicenter, clinical study to evaluate the safety and effectiveness of both an embolic agent and infusion catheter for a non-surgical treatment of symptomatic uterine fibroids. Women who are 30 years of age or older and who have been diagnosed with symptomatic uterine fibroids may be eligible to participate. Research sites located in Philadelphia and Atlanta.

More Information

Please see http://www.centerwatch.com/patient/studies/cat322.html.

-----

Diabetes Mellitus Types I and II

A research study of an investigational medication for Type II non-insulin dependent diabetics who are taking medications for their diabetes. Volunteers who have non-insulin dependent diabetes and are over 18 years old may be eligible to participate. Research site located in Rochester, New York.

More Information

Please see http://www.centerwatch.com/patient/studies/cat55.html.

-----

Malignant Melanoma

A study to determine if patients with metastatic melanoma (a type of spreading skin cancer) who receive the study drug after surgery live longer than patients who receive standard chemotherapy. Male and female volunteers who are at least 18 years of age and have stage IV melanoma may be able to participate. Research site located in Kansas City, Kansas.

More Information

Please see http://www.centerwatch.com/patient/studies/cat196.html.

-----

Copyright 2002 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.